Advertisement

Topics

Pembrolizumab promising for pretreated metastatic gastric cancer

05:00 EDT 8 Sep 2017 | Medical Xpress

Pembrolizumab has shown a promising response rate in patients with pretreated metastatic gastric cancer, according to late-breaking results from the KEYNOTE-059 trial presented today at the ESMO 2017 Congress in Madrid.

Original Article: Pembrolizumab promising for pretreated metastatic gastric cancer

NEXT ARTICLE

More From BioPortfolio on "Pembrolizumab promising for pretreated metastatic gastric cancer"

Quick Search
Advertisement